Companies Do Not Publish All Adverse Events from Sponsored Clinical Trials

An analysis of published and unpublished adverse events reports from clinical trials shows that much of the adverse event data is not published in peer-reviewed journals. The authors concluded that peer-reviewed journals are not a reliable source for all adverse events identified for a given drug. The authors recommended that interested parties should look at other sources … Read more

Should FDA Accept Data From Clinical Trials Conducted in China?

This week the Chinese FDA announced results of its year-long investigation into clinical trials conducted in China, and the results were appalling. But its impact on Chinese manufactured drugs sold in the US is likely minimal, at least in the near future. Chinese auditors found that more than 80% of clinical trials contained fabricated and fraudulent data, … Read more

Final Rule for Mandatory Reporting of Clinical Trials Results on Clinicaltrials.gov: No Excuses

Last week, NIH released the final rule for registering clinical trials and reporting results for completed studies. The most important part of the final rule is regarding the submission of results from completed clinical trials. Starting 18 Jan 2017, all completed clinical trials will be required to submit results on clinicaltrials.gov within 1-3 years of study completion … Read more

Strict Food Quality Rules Come into Effect This Week: FSMA Compliance

The first stage of the implementation of the Food Safety Modernization Act (FSMA) officially came into effect this Monday (19 Sep 2016) whereby all large food manufacturers, with 500 or more employees, have to be in compliance with strict food quality and contamination prevention standards. The food GMP regulations require manufacturers to control all aspects of growth, … Read more

Are E-Cigarettes Good Smoking Cessation Products? Depends on Who You Ask.

FDA has decided that e-cigarettes should be treated the same way as conventional cigarettes but in the medical community there are strong opinions regarding whether these products should be promoted for smoking cessation or discouraged for their potential to promote smoking. It has long been argued that electronic cigarettes are less harmful due to lack of tar, … Read more

FDA Announces Plan to Release About 100 New Guidance Documents

For the calendar year 2016, CDER at FDA plans to release more than 100 new guidance documents in 15 areas of interest. The list of guidance documents is a good indicator of FDA-industry interactions and current areas of interest and this year’s list is no different. Several of these will be eagerly awaited by the industry. There … Read more

Is Direct-to-consumer Advertisement Misleading?

The United States and New Zealand are the only two countries in the World that allow direct-to-consumer (DTC) advertisement. Each year the US pharma industry spends almost $5 billion on such ads. However, the American Medical Association that represents the doctors believe DTC ads push patients towards costly new drugs with limited experience compared to established treatment … Read more

Five Lessons from Hillary’s Email Saga: Why Part 11 Should be a Universal Best Practice

Bernie Sanders famously said that “people are sick of hearing about Hillary Clinton’s “damn emails”, and perhaps he was right. However, the findings from the FBI investigation of the matter continue to highlight several issues with email security common with many senior executives. Part 11 regulations provide some of the best policies for system integrity and data storage that … Read more

Does it Matter if Your CRO is Big or Small?

A common question asked when choosing a suitable contract research organization (CRO) is if one should go with a big CRO or a small CRO. There are 751 CROs in the World with about half of them or 332 in the US. Of these, the top 10 CROs account for about 57% of the total revenue in the … Read more